- Trials with a EudraCT protocol (52)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
52 result(s) found for: Drug Rehabilitation.
Displaying page 1 of 3.
EudraCT Number: 2009-017925-20 | Sponsor Protocol Number: RR08/8789 | Start Date*: 2010-09-07 | ||||||||||||||||
Sponsor Name:University of Leeds | ||||||||||||||||||
Full Title: Does Cocareldopa treatment in combination with routine NHS occupational and physical therapy, delivered early after stroke within a stroke service, improve functional recovery including walking and... | ||||||||||||||||||
Medical condition: Ischaemic or Haemorrhagic Stroke | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-001090-23 | Sponsor Protocol Number: STH14394 | Start Date*: 2006-06-13 |
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | ||
Full Title: Testosterone therapy as an adjunct to exercise rehabilitation: effects on exercise capacity, inflammatory markers and quality of life in hypogonadal males with chronic heart failure. | ||
Medical condition: Congestive heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-001684-50 | Sponsor Protocol Number: 11015 | Start Date*: 2011-06-20 |
Sponsor Name:University of Nottingham | ||
Full Title: 'Stem cell Trial of recovery EnhanceMent after Stroke 3’ (STEMS 3)- a pilot randomised controlled trial of G-CSF and therapy in chronic stroke | ||
Medical condition: Stroke with residual deficit | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002396-17 | Sponsor Protocol Number: NA | Start Date*: 2013-12-04 |
Sponsor Name:Birmingham Community Healthcare NHS Trust | ||
Full Title: The effect of Pramipexole on recovery from chronic post-stroke aphasia | ||
Medical condition: Post-stroke aphasia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001385-16 | Sponsor Protocol Number: BACTstudy | Start Date*: 2019-11-22 |
Sponsor Name:Clinic for Medicine and rehabilitation, Nord-Trondelag Trust (HNT) | ||
Full Title: Botulinum toxin A in frequent and chronic tension-type headache. A double blind, randomized, placebo-controlled cross-over trial | ||
Medical condition: Frequent and chronic tension-type headache | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002650-67 | Sponsor Protocol Number: IBERepic/2018 | Start Date*: 2018-11-15 |
Sponsor Name:Ibermutuamur (Mutua Colaboradora con la Seguridad Social nº 274) | ||
Full Title: Comparison of the efficacy of autologous platelet rich plasma injections, and extracorporeal shock wave therapy, in the treatment of work –related lateral epicondylitis. | ||
Medical condition: The epicondylitis is an overuse injury, in most cases, is a self-limited course and responds well to conservative treatment. Its etiology is degenerative and is related to a repetitive overuse and ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003945-10 | Sponsor Protocol Number: 01-APN-08 | Start Date*: 2009-01-20 |
Sponsor Name:Centre hospitalier universitaire de nice | ||
Full Title: ACTION OF THE AMANTADINE ON POST STROKE APHASIC PATIENTS LANGUAGE AND COMMUNICATION | ||
Medical condition: post stroke chronic aphasia patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-002131-34 | Sponsor Protocol Number: GS-US-357-1394 | Start Date*: 2015-05-07 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects with Pulmonary Arterial Hypertension | |||||||||||||
Medical condition: Men and women, ages 18 through 75 years, with a diagnosis of idiopathic PAH, heritable PAH or PAH associated with connective tissue disease (PAH-CTD), congenital heart defects (repaired), drug and ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Completed) ES (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002708-26 | Sponsor Protocol Number: CRC341 | Start Date*: 2017-06-28 | ||||||||||||||||
Sponsor Name:University of Surrey | ||||||||||||||||||
Full Title: A randomised double blind placebo controlled pilot trial of oxytocin efficacy in treating detoxified opioid dependent individuals | ||||||||||||||||||
Medical condition: Opioid dependence. The study will be investigating the efficacy of Syntocinon (oxytocin) on treating the withdrawal symptoms and cravings that opioid (e.g. almost always heroin) dependent individua... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-004971-42 | Sponsor Protocol Number: RVT-1201-2002 | Start Date*: 2021-10-26 | |||||||||||
Sponsor Name:Altavant Sciences GmbH | |||||||||||||
Full Title: A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension | |||||||||||||
Medical condition: Pulmonary Arterial Hypertension (PAH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) LV (Prematurely Ended) BE (Completed) CZ (Prematurely Ended) PL (Prematurely Ended) IT (Prematurely Ended) BG (Prematurely Ended) ES (Ongoing) AT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007455-26 | Sponsor Protocol Number: GS-US-235-0101 | Start Date*: 2010-01-21 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter, Dose-ranging Study of Cicletanine in Subjects with Pulmonary Arterial Hypertension | |||||||||||||
Medical condition: Pulmonary hypertension (PH) is a serious and life-threatening disease of the pulmonary vasculature, characterized by profound vasoconstriction and an abnormal proliferation of smooth muscle cells i... | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) DE (Prematurely Ended) BE (Prematurely Ended) GB (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021414-32 | Sponsor Protocol Number: A9541004 | Start Date*: 2010-11-23 | |||||||||||
Sponsor Name:Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK | |||||||||||||
Full Title: A PHASE 2 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF PF-03049423 IN SUBJECTS WITH ISCHEMIC STROKE | |||||||||||||
Medical condition: ISCHEMIC STROKE | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) DE (Prematurely Ended) BG (Prematurely Ended) CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014909-14 | Sponsor Protocol Number: CS/München01 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Max-Planck-Institut für Psychiatrie | |||||||||||||
Full Title: Neuropsychological effects of hydrocortisone substitution in patients with partial adrenal insufficiency after traumatic brain injury or subarachnoidal haemorrhage | |||||||||||||
Medical condition: hormonal deficiency after traumatic-brain- injury (TBI) or subarachnoidal haemorrhage (SAH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003564-57 | Sponsor Protocol Number: Adalimumab1- 2006 | Start Date*: 2006-11-02 | |||||||||||
Sponsor Name:Kuopio University Hospital | |||||||||||||
Full Title: Adalimumab (anti TNF alfa) in the management of acute lumbar disc prolapses -a one year, randomized, placebo controlled, double blind, single center trial | |||||||||||||
Medical condition: Patients with acute or subacute (no more than 2 months) clinical sciatica caused by herniated disc prolapse | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018920-21 | Sponsor Protocol Number: ZICBOL2010 | Start Date*: 2011-03-23 | |||||||||||
Sponsor Name:Landstinget i Östergötland | |||||||||||||
Full Title: Evaluation of a Structured Algorithm for Intrathecal Bolus Doses of Ziconotide(Prialt®) - The Swedish Ziconotide Bolus Study | |||||||||||||
Medical condition: Chronic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000647-27 | Sponsor Protocol Number: Ibu19 | Start Date*: 2019-12-18 | ||||||||||||||||
Sponsor Name:Dicofarm S.p.A. | ||||||||||||||||||
Full Title: Evaluation of efficacy and bioavailability of a new pediatric formulation based on ibuprofen lysinate vs ibuprofen in the management of pain in children | ||||||||||||||||||
Medical condition: Pain on an inflammatory basis (otitis and otomastoiditis, adenite, cellulite, arthritis) and post-operative pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004215-30 | Sponsor Protocol Number: BRD/05/155 | Start Date*: 2006-02-24 |
Sponsor Name:Joint Sponsorship: University College London (UCL) & University College London Hospitals (UCLH) | ||
Full Title: Imaging the neural correlates of cholinergic and behaviour driven rehabilitation in patients with Wernicke’s aphasia: a double-blinded, cross-over, randomised controlled trial. | ||
Medical condition: Wernicke's aphasia caused by a stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000906-52 | Sponsor Protocol Number: SC0806-A101 | Start Date*: 2015-03-24 |
Sponsor Name:BioArctic AB | ||
Full Title: An Open, Randomized, Rehabilitation-controlled Study to Assess Safety, Tolerability, and Efficacy of Heparin Activated Recombinant Human Fibroblast Growth Factor 1 on a Biodegradable Device in Subj... | ||
Medical condition: Complete Traumatic Spinal Cord Injury (TSCI) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) NO (Completed) EE (Prematurely Ended) FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-002418-18 | Sponsor Protocol Number: 2021-10 | Start Date*: 2022-11-09 |
Sponsor Name:University Hospital Tübingen | ||
Full Title: AmaNtadine for NeuroenhancEment in acutE patients Study - A prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES) | ||
Medical condition: Patients on Intermediate Care and Intensive Care Unit (IMC and ICU) with unresponsive wakefulness syndrome not otherwise explained | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001910-13 | Sponsor Protocol Number: AV-101-002 | Start Date*: 2022-02-21 | ||||||||||||||||||||||||||
Sponsor Name:Aerovate Therapeutics, Inc. | ||||||||||||||||||||||||||||
Full Title: IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients with Pulmonary Arterial Hy... | ||||||||||||||||||||||||||||
Medical condition: Pulmonary Arterial Hypertension (PAH) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FR (Trial now transitioned) ES (Ongoing) IT (Ongoing) NL (Ongoing) CZ (Trial now transitioned) PT (Trial now transitioned) IE (Trial now transitioned) AT (Trial now transitioned) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.